Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 32Recruiting 4Not yet recruiting 4Unknown 2Active not recruiting 2Withdrawn 1Terminated 1Suspended 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 46Breast Neoplasms 46Colorectal Neoplasms 27Prostatic Neoplasms 26Carcinoma, Non-Small-Cell Lung 21Leukemia, Myeloid, Acute 20Glioblastoma 19Melanoma 17Lung Neoplasms 17Pancreatic Neoplasms 16Neoplasm Metastasis 16Glioma 14Stomach Neoplasms 13Ovarian Neoplasms 13Brain Neoplasms 13Carcinoma, Hepatocellular 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myelodysplastic Syndromes 11Triple Negative Breast Neoplasms 10Multiple Myeloma 10Head and Neck Neoplasms 10Carcinoma, Renal Cell 10Lymphoma 9Uterine Cervical Neoplasms 7Sarcoma 7Rectal Neoplasms 7Leukemia 7Hematologic Neoplasms 7Esophageal Neoplasms 7Colonic Neoplasms 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Medication Adherence × Clear all
NCT04091711 2021-09-20

Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics

Dosentrx Ltd.

Phase NA Suspended
20 enrolled

Neoplasms, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡